Medregen, LLC

City:

Baltimore, Maryland

Country:

United States

Published Applications:

Last publication date:

2025-02-13

Patent Grants:

Last grant date:

2024-10-15

Top Inventors for applications by Medregen, LLC

These are the the leading inventors for applications assigned to Medregen, LLC:

Zhaoli Sun 6 Perry Hall, MD United States
George Melville Williams 3 Stuart, FL United States
Zhimin Liu 2 Greenville, NC United States
Richard Brewer 2 Greenville, NC United States

Rachel Labell 2 Greenville, NC United States
Mitchell Williams 2 Greenville, NC United States
Isaac Agyemang 2 Greenville, NC United States
John Sun 2 Baltimore, MD United States

Christy Eatmon 2 Greenville, NC United States
Xuhang Li 2 Clarksville, MD United States
Qing Lin 2 Baltimore, MD United States
Zhaoli Sun 2 Baltimore, MD United States

George Melville Williams 1 Arnold, MD United States
Ali Reza Ahmadi 1 Ridderkerk, Netherlands
Jared Griffin 1 Greenville, NC United States
Issac Agyemang 1 Greenville, NC United States

Recent patent applications by Medregen, LLC

Medregen, LLC based in Baltimore, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-02-13

US20250049767A1

Human necessities

FORMULATIONS, METHODS, KITS, AND DOSAGE FORMS

#2 | 2025-01-16

US20250017912A1

Human necessities

METHODS FOR DOWN-REGULATION AND UP-REGULATION OF PATHWAYS

#3 | 2022-05-12 ✅ Patent 12,115,149 granted on 2024-10-15

US20220142992A1

Human necessities

Formulations, methods, kits, and dosage forms

#4 | 2021-08-19 ✅ Patent 12,048,687 granted on 2024-07-30

US20210251954A1

Human necessities

Methods of recruiting SDF-producing macrophages

#5 | 2020-02-06 ✅ Patent 11,291,657 granted on 2022-04-05

US20200038381A1

Human necessities

Methods of treating inflammatory bowel disease with AMD3100 and Tacrolimus

#6 | 2016-04-21 ✅ Patent 10,945,993 granted on 2021-03-16

US20160106710A1

Human necessities

Methods of recruiting SDF-producing macrophages

#7 | 2016-01-14 ✅ Patent 10,420,751 granted on 2019-09-24

US20160008331A1

Human necessities

Methods of treating inflammatory bowel disease with AMD3100 and tacrolimus

#8 | 2013-02-28 ✅ Patent 10,813,917 granted on 2020-10-27

US20130052231A1

Human necessities

Treatment methods utilizing stem cell mobilizers and immunosuppressive agents

Also check out MedRegen, LLC's (Baltimore, United States) applicant profile with 6 patent applications submitted.

AssigneeID:

375604 ⎘